These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 16998244

  • 21. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [Abstract] [Full Text] [Related]

  • 22. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
    McCarthy DM, Brat DJ, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH.
    Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Second surgery after a pancreaticoduodenectomy in patients with periampullary malignancies.
    Nakano H, Asakura T, Koizumi S, Asano T, Watanabe T, Otsubo T, Takizawa K.
    Hepatogastroenterology; 2008 Jun; 55(82-83):687-91. PubMed ID: 18613434
    [Abstract] [Full Text] [Related]

  • 25. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.
    Shimada K, Sano T, Sakamoto Y, Kosuge T.
    Ann Surg Oncol; 2006 Dec; 13(12):1569-78. PubMed ID: 17009145
    [Abstract] [Full Text] [Related]

  • 26. [Repeated resections of asynchronous liver metastases after pancreatomy for pancreatic cancer--a case report].
    Hayashi N, Soma I, Nakano K, Higaki N, Murakami M, Hayashida H, Kan K, Ichihara T, Sakon M.
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2410-2. PubMed ID: 20037439
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma.
    Muroni M, D'Angelo F, Pezzatini M, Sebastiani S, Noto S, Pilozzi E, Ramacciato G.
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):97-9. PubMed ID: 20133238
    [Abstract] [Full Text] [Related]

  • 29. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C.
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [Abstract] [Full Text] [Related]

  • 30. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
    Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y.
    Pancreatology; 2016 Nov; 16(4):615-20. PubMed ID: 27237099
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss.
    Kazanjian KK, Hines OJ, Duffy JP, Yoon DY, Cortina G, Reber HA.
    Arch Surg; 2008 Dec; 143(12):1166-71. PubMed ID: 19075167
    [Abstract] [Full Text] [Related]

  • 35. [Surgical standard therapy for cancer of the pancreas].
    Friess H, Kleeff J, Fischer L, Müller M, Büchler MW.
    Chirurg; 2003 Mar; 74(3):183-90. PubMed ID: 12647074
    [Abstract] [Full Text] [Related]

  • 36. Resection of cancer of the body and tail of the pancreas.
    Burcharth F, Trillingsgaard J, Olsen SD, Moesgaard F, Federspiel B, Struckmann JR.
    Hepatogastroenterology; 2003 Mar; 50(50):563-6. PubMed ID: 12749273
    [Abstract] [Full Text] [Related]

  • 37. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM, Schulick RD, Pawlik TM.
    Cancer; 2007 Dec 01; 110(11):2484-92. PubMed ID: 17941009
    [Abstract] [Full Text] [Related]

  • 38. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
    Naseef O, Adham M, Hervieu V, Le Borgne J, Partensky C.
    Hepatogastroenterology; 2008 Dec 01; 55(84):1110-1. PubMed ID: 18705340
    [Abstract] [Full Text] [Related]

  • 39. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
    Bergmann F, Ceyhan GO, Rieker RJ, Esposito I, Fischer L, Herpel E, Friess H, Schirmacher P, Kern MA.
    Hum Pathol; 2009 Jan 01; 40(1):50-7. PubMed ID: 18789481
    [Abstract] [Full Text] [Related]

  • 40. A resected case of solitary pancreatic metastasis from adenocarcinoma of the lung.
    Mori N, Sawada T, Satoh H, Kawaguchi M, Hara H, Matsushita K.
    JOP; 2008 Nov 03; 9(6):698-703. PubMed ID: 18981550
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.